Prevalence of neutralising antibodies to interferon-beta and clinical response in Chinese patients with relapsing multiple sclerosis

BACKGROUND: There are no data on neutralising antibodies to interferon-beta and its clinical implications in Chinese patients with multiple sclerosis (MS). OBJECTIVES: The objectives of this study were to investigate the prevalence of neutralising antibodies among Chinese patients with relapsing MS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mult Scler J Exp Transl Clin
Main Authors: Lau, Alexander Y, Ip, WK, Au, Cheryl, Lau, KK, Wong, Winnie, Yip, KK, Yeung, Jonas, Li, SH, Li, Patrick, Lee, Ryan, Siu, Deyond, Abrigo, Jill, Wong, Adrian, Mok, Vincent, Chan, Eric
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2017
Assuntos:
Original Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5637981/
https://ncbi.nlm.nih.gov/pubmed/29051830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217317733485
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados